prolong ventricular refractori class Ia antiarrhythm drug prevent ventricular tachycardia induct effect class la antiarrhythm drug procainamid quinidin right ventricular effect refractori period verp intraventricular conduct time serial invas electrophysiolog studi sustain monomorph ventricular tachycardia VT patient remot myocardi infarct VT induc extrastimuli basic drive basic cycl length right ventricular apex oral drug administr VT induc group patient induc group II protocol class la drug verp group drug effect msec group msec group II basic cycl length msec prolong verp msec posit predict valu prevent sustain VT induct patient group drug verp coupl interv sustain VT induct control condit attain contrast conduct time ventricl surfac qr durat sinu rhythm right ventricular pace efficaci msec vs msec cycl length msec presenc similar plasma level drug equival prolong verp group result prolong verp oral procainamid correl drug efficaci VT induct predictor drug effect achiev therapeut plasma level 